behavior/neurological
• daily treatment with amphetamine enhances locomotor responses in male control mice but does not affect male mutants; 1 week after cessation of treatment robust locomotor sensitization persists in controls
|
• control mice exhibit greater locomotor response when treated with a Grm5 antagonist, MPEP, than forebrain-specific knockout mice
(J:102700)
• in response to the adenosine (A2a) agonist KW-6002, locomotion is induced in male control animals but not in conditional knockout mice
(J:104338)
• enhancement of fine movement behavior in male controls is observed in response to amphetamine treatment but not in knockouts
(J:104338)
|